Skip to main content
DA / EN

News

Master Students 2025

6 master students  finish their degree in Biochemistry and Molecular Biology or Biomedicine with projects in our lab.

Ida Emilie Jørgensen - exploring the function of the RBM12 protein and mutations in RBM12 in relation to disease.

Lærke Borgen Mikkelsen - exploring SSO-based modulation of LRRK2 gene expression in Parkinson's Disease

 

Inverna Therapeutics

Inverna Therapeutics is a biotech company established in 2025 as a spin-off of the RNA splicing and disease research group.

Inverna Therapeutics is dedicated to developing transformative RNA therapeutics based on RNA splicing modulation.

https://www.invernatx.com/

Department of Biochemistry and Molecular Biology University of Southern Denmark

  • Campusvej 55
  • Odense M - DK-5230
  • Phone: +45 6550 2412

Last Updated 20.06.2025